New treatments for idiopathic pulmonary fibrosis: 'Die another day' if diagnosed early?

Respiration

Volumn 90, Issue 4, 2015, Pages 352-

  Antoniou, Katerina M ^a   Symvoulakis, Emmanouil K ^b   Anyfantakis, Dimitrios ^c   Wells, Athol U ^d  

^a UNIVERSITY OF CRETE   (Greece)

^b Private Family Practice Unit in Heraklion   (Greece)

^c Primary Health Care Centre of Kissamos   (Greece)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; NINTEDANIB; PIRFENIDONE;

AWARENESS; EARLY DIAGNOSIS; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; HUMAN; LETTER; LUNG AUSCULTATION; PATIENT REFERRAL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SPIROMETRY; SURVIVAL; IDIOPATHIC PULMONARY FIBROSIS;

EARLY DIAGNOSIS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS;

EID: 84946498583     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000436980     Document Type: Letter

References (8)

1. Antoniou KM, Symvoulakis EK, Margaritopoulos GA, Lionis C, Wells AU. Early diagnosis of IPF: time for a primary-care case-finding initiative?. Lancet Respir Med 2014; 2: e1
2. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011; 378: 1949-1956
3. Raghu G. Idiopathic pulmonary fibrosis: new evidence and an improved standard of care in 2012. Lancet 2012; 380: 699-670
4. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR; INPULSIS Trial Investigators: Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2071-2082
5. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW; ASCEND Study Group: A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2083-2092
6. Jones MG, Fletcher S, Richeldi L. Idiopathic pulmonary fibrosis: recent trials and current drug therapy. Respiration 2013; 86: 353-363
7. Lamas DJ, Kawut SM, Bagiella E, Philip N, Arcasoy SM, Lederer DJ. Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med 2011; 184: 842-847
8. Oltmanns U, Kahn N, Palmowski K, Träger A, Wenz H, Heussel CP, Schnabel PA, Puderbach M, Wiebel M, Ehlers-Tenenbaum S, Warth A, Herth FJ, Kreuter M. Pirfenidone in idiopathic pulmonary fibrosis: reallife experience from a German tertiary referral center for interstitial lung diseases. Respiration 2014; 88: 199-207